• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA 调控胶质母细胞瘤中的细胞周期和细胞死亡途径。

MicroRNAs Regulate Cell Cycle and Cell Death Pathways in Glioblastoma.

机构信息

Brain Research Institute Monash Sunway [BRIMS], Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway 47500, Malaysia.

出版信息

Int J Mol Sci. 2021 Dec 17;22(24):13550. doi: 10.3390/ijms222413550.

DOI:10.3390/ijms222413550
PMID:34948346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8705881/
Abstract

Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogenicity and its resistance to the current treatment regimen. Over the last few decades, a significant amount of new molecular and genetic findings has been reported regarding factors contributing to GBM's development into a lethal phenotype and its overall poor prognosis. MicroRNA (miRNAs) are small non-coding sequences of RNA that regulate and influence the expression of multiple genes. Many research findings have highlighted the importance of miRNAs in facilitating and controlling normal biological functions, including cell differentiation, proliferation, and apoptosis. Furthermore, miRNAs' ability to initiate and promote cancer development, directly or indirectly, has been shown in many types of cancer. There is a clear association between alteration in miRNAs expression in GBM's ability to escape apoptosis, proliferation, and resistance to treatment. Further, miRNAs regulate the already altered pathways in GBM, including P53, RB, and PI3K-AKT pathways. Furthermore, miRNAs also contribute to autophagy at multiple stages. In this review, we summarize the functions of miRNAs in GBM pathways linked to dysregulation of cell cycle control, apoptosis and resistance to treatment, and the possible use of miRNAs in clinical settings as treatment and prediction biomarkers.

摘要

胶质母细胞瘤(GBM)是一种 4 级脑肿瘤,其异质性和对当前治疗方案的耐药性是众所周知的。在过去的几十年中,已经报道了大量关于导致 GBM 发展为致命表型及其总体预后不良的因素的新分子和遗传发现。微小 RNA(miRNAs)是一种调节和影响多个基因表达的小型非编码 RNA 序列。许多研究结果强调了 miRNAs 在促进和控制正常生物学功能(包括细胞分化、增殖和凋亡)方面的重要性。此外,miRNAs 能够直接或间接地启动和促进癌症的发展,这在许多类型的癌症中都得到了证实。在 GBM 中,miRNAs 表达的改变与逃避凋亡、增殖和治疗耐药性的能力之间存在明显的关联。此外,miRNAs 还调节 GBM 中已经改变的途径,包括 P53、RB 和 PI3K-AKT 途径。此外,miRNAs 还在多个阶段参与自噬。在这篇综述中,我们总结了 miRNAs 在与细胞周期控制失调、凋亡和治疗耐药性相关的 GBM 途径中的功能,以及 miRNAs 在临床作为治疗和预测生物标志物的可能用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0855/8705881/6162674701f2/ijms-22-13550-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0855/8705881/4773f774aa9f/ijms-22-13550-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0855/8705881/6162674701f2/ijms-22-13550-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0855/8705881/4773f774aa9f/ijms-22-13550-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0855/8705881/6162674701f2/ijms-22-13550-g002.jpg

相似文献

1
MicroRNAs Regulate Cell Cycle and Cell Death Pathways in Glioblastoma.微小 RNA 调控胶质母细胞瘤中的细胞周期和细胞死亡途径。
Int J Mol Sci. 2021 Dec 17;22(24):13550. doi: 10.3390/ijms222413550.
2
MicroRNAs as prognostic markers and therapeutic targets in gliomas.微小RNA作为胶质瘤的预后标志物和治疗靶点
Noncoding RNA Res. 2022 Jul 6;7(3):171-177. doi: 10.1016/j.ncrna.2022.07.001. eCollection 2022 Sep.
3
Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.外泌体miR-1238 的转移促进胶质母细胞瘤对替莫唑胺的耐药性。
EBioMedicine. 2019 Apr;42:238-251. doi: 10.1016/j.ebiom.2019.03.016. Epub 2019 Mar 24.
4
Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.胶质母细胞瘤患者同步放化疗后 MicroRNAs 的差异表达。
OMICS. 2013 May;17(5):259-68. doi: 10.1089/omi.2012.0065. Epub 2013 Apr 15.
5
MicroRNAs involved in the EGFR pathway in glioblastoma.胶质母细胞瘤中涉及 EGFR 通路的 microRNAs。
Biomed Pharmacother. 2021 Feb;134:111115. doi: 10.1016/j.biopha.2020.111115. Epub 2020 Dec 16.
6
MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma.微小RNA对胶质母细胞瘤糖酵解代谢的调控
Biomed Res Int. 2017;2017:9157370. doi: 10.1155/2017/9157370. Epub 2017 Jul 19.
7
Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.胶质母细胞瘤中针对miRNA-21和PDCD4的靶向策略。
Arch Biochem Biophys. 2015 Aug 15;580:64-74. doi: 10.1016/j.abb.2015.07.001. Epub 2015 Jul 2.
8
Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells.PX-866 通过抑制磷脂酰肌醇 3-激酶抑制替莫唑胺诱导的脑胶质瘤细胞自噬并促进其凋亡。
Mol Med. 2019 Nov 14;25(1):49. doi: 10.1186/s10020-019-0116-z.
9
MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells.MiR224-3p通过靶向人胶质母细胞瘤细胞中的自噬相关基因来抑制缺氧诱导的自噬。
Oncotarget. 2015 Dec 8;6(39):41620-37. doi: 10.18632/oncotarget.5871.
10
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.微小RNA-135b通过损害增殖、迁移和自我更新来抑制胶质母细胞瘤干细胞样细胞的肿瘤发生。
Oncotarget. 2015 Nov 10;6(35):37241-56. doi: 10.18632/oncotarget.5925.

引用本文的文献

1
Progenitor cells, microglia, and non-coding RNAs: Orchestrators of glioblastoma pathogenesis and therapeutic resistance.祖细胞、小胶质细胞与非编码RNA:胶质母细胞瘤发病机制及治疗耐药性的调控者
Noncoding RNA Res. 2025 Aug 5;15:85-99. doi: 10.1016/j.ncrna.2025.07.007. eCollection 2025 Dec.
2
Ferroptosis rewired: ncRNA gatekeepers as pharmacological targets in hepatocellular carcinoma.铁死亡重编程:非编码RNA守门人作为肝细胞癌的药理学靶点
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 7. doi: 10.1007/s00210-025-04404-4.
3
Machine learning approaches for predicting the small molecule-miRNA associations: a comprehensive review.

本文引用的文献

1
The Risks of miRNA Therapeutics: In a Drug Target Perspective.miRNA 治疗的风险:从药物靶点角度看。
Drug Des Devel Ther. 2021 Feb 22;15:721-733. doi: 10.2147/DDDT.S288859. eCollection 2021.
2
MicroRNAs involved in the EGFR pathway in glioblastoma.胶质母细胞瘤中涉及 EGFR 通路的 microRNAs。
Biomed Pharmacother. 2021 Feb;134:111115. doi: 10.1016/j.biopha.2020.111115. Epub 2020 Dec 16.
3
Different T-cell subsets in glioblastoma multiforme and targeted immunotherapy.胶质母细胞瘤中的不同 T 细胞亚群及靶向免疫治疗。
用于预测小分子与微小RNA关联的机器学习方法:全面综述
Mol Divers. 2025 May 20. doi: 10.1007/s11030-025-11211-9.
4
RNA Structure: Past, Future, and Gene Therapy Applications.RNA结构:过去、未来及基因治疗应用
Int J Mol Sci. 2024 Dec 26;26(1):110. doi: 10.3390/ijms26010110.
5
Research progress of drug resistance mechanism of temozolomide in the treatment of glioblastoma.替莫唑胺治疗胶质母细胞瘤耐药机制的研究进展
Heliyon. 2024 Oct 30;10(21):e39984. doi: 10.1016/j.heliyon.2024.e39984. eCollection 2024 Nov 15.
6
Genetic Associations of Plasminogen Activator Inhibitor-1-Related miRNA Variants with Coronary Artery Disease.纤溶酶原激活物抑制剂-1 相关 miRNA 变异与冠状动脉疾病的遗传关联。
Int J Mol Sci. 2024 Oct 27;25(21):11528. doi: 10.3390/ijms252111528.
7
MicroRNAs as Biomarkers of Brain Tumor.微小RNA作为脑肿瘤的生物标志物
Cancer Manag Res. 2024 Oct 4;16:1353-1361. doi: 10.2147/CMAR.S484158. eCollection 2024.
8
Unravelling the mosaic: Epigenetic diversity in glioblastoma.解析镶嵌现象:胶质母细胞瘤中的表观遗传多样性
Mol Oncol. 2024 Dec;18(12):2871-2889. doi: 10.1002/1878-0261.13706. Epub 2024 Aug 15.
9
miRNA Signatures in Bronchopulmonary Dysplasia: Implications for Biomarkers, Pathogenesis, and Therapeutic Options.miRNA 特征在支气管肺发育不良中的作用:对生物标志物、发病机制和治疗选择的启示。
Front Biosci (Landmark Ed). 2024 Jul 25;29(7):271. doi: 10.31083/j.fbl2907271.
10
The potential of miRNA-based approaches in glioblastoma: An update in current advances and future perspectives.基于微小RNA的方法在胶质母细胞瘤中的潜力:当前进展与未来展望的最新情况
Curr Res Pharmacol Drug Discov. 2024 Jun 29;7:100193. doi: 10.1016/j.crphar.2024.100193. eCollection 2024.
Cancer Lett. 2021 Jan 1;496:134-143. doi: 10.1016/j.canlet.2020.09.028. Epub 2020 Oct 3.
4
Inflammatory Mediators in Glioma Microenvironment Play a Dual Role in Gliomagenesis and Mesenchymal Stem Cell Homing: Implication for Cellular Therapy.胶质瘤微环境中的炎症介质在胶质瘤发生和间充质干细胞归巢中起双重作用:对细胞治疗的启示
Mayo Clin Proc Innov Qual Outcomes. 2020 Aug 5;4(4):443-459. doi: 10.1016/j.mayocpiqo.2020.04.006. eCollection 2020 Aug.
5
MicroRNA-93 acts as an "anti-inflammatory tumor suppressor" in glioblastoma.微小RNA-93在胶质母细胞瘤中作为一种“抗炎性肿瘤抑制因子”发挥作用。
Neurooncol Adv. 2020 Apr 18;2(1):vdaa047. doi: 10.1093/noajnl/vdaa047. eCollection 2020 Jan-Dec.
6
LncRNA-XIST/microRNA-126 sponge mediates cell proliferation and glucose metabolism through the IRS1/PI3K/Akt pathway in glioma.LncRNA-XIST/miRNA-126 海绵通过 IRS1/PI3K/Akt 通路介导脑胶质瘤细胞增殖和糖代谢。
J Cell Biochem. 2020 Mar;121(3):2170-2183. doi: 10.1002/jcb.29440. Epub 2019 Nov 3.
7
DNA repair in cancer initiation, progression, and therapy-a double-edged sword.癌症发生、进展和治疗中的 DNA 修复——一把双刃剑。
J Appl Genet. 2019 Nov;60(3-4):329-334. doi: 10.1007/s13353-019-00516-9. Epub 2019 Aug 30.
8
Genetic and molecular epidemiology of adult diffuse glioma.成人弥漫性神经胶质瘤的遗传和分子流行病学。
Nat Rev Neurol. 2019 Jul;15(7):405-417. doi: 10.1038/s41582-019-0220-2. Epub 2019 Jun 21.
9
miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2.miR-26a 通过抑制 PTEN 促进肝癌侵袭和转移,并通过抑制 EZH2 抑制细胞生长。
Lab Invest. 2019 Oct;99(10):1484-1500. doi: 10.1038/s41374-019-0270-5. Epub 2019 Jun 14.
10
Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.miR-126 在胶质瘤中靶向调控 PTEN/PI3K/Akt 和 MDM2-p53 通路的研究。
Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3461-3470. doi: 10.26355/eurrev_201904_17711.